Annual SG&A
$67.39 M
+$5.92 M+9.64%
31 December 2023
Summary:
Biodesix annual selling, general & administrative expenses is currently $67.39 million, with the most recent change of +$5.92 million (+9.64%) on 31 December 2023. During the last 3 years, it has risen by +$32.53 million (+93.32%). BDSX annual SG&A is now at all-time high.BDSX Selling, General & Administrative Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly SG&A
$20.02 M
+$356.00 K+1.81%
30 September 2024
Summary:
Biodesix quarterly selling, general & administrative expenses is currently $20.02 million, with the most recent change of +$356.00 thousand (+1.81%) on 30 September 2024. Over the past year, it has increased by +$4.52 million (+29.17%). BDSX quarterly SG&A is now -2.63% below its all-time high of $20.56 million, reached on 31 March 2024.BDSX Quarterly SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM SG&A
-$1.75 B
-$43.82 M-2.57%
30 September 2024
Summary:
Biodesix TTM selling, general & administrative expenses is currently -$1.75 billion, with the most recent change of -$43.82 million (-2.57%) on 30 September 2024. Over the past year, it has dropped by -$1.82 billion (-2684.01%). BDSX TTM SG&A is now -669.78% below its all-time high of $76.48 million, reached on 30 September 2024.BDSX TTM SG&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
BDSX Selling, General & Administrative Expenses Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +9.6% | +29.2% | -2684.0% |
3 y3 years | +93.3% | +47.1% | -3671.8% |
5 y5 years | +160.2% | +143.7% | -10000.0% |
BDSX Selling, General & Administrative Expenses High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | at high | +93.3% | -2.6% | +47.6% | -60.6% | at low |
5 y | 5 years | at high | +160.2% | -2.6% | +205.3% | -669.8% | at low |
alltime | all time | at high | +160.2% | -2.6% | +205.3% | -669.8% | at low |
Biodesix Selling, General & Administrative Expenses History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | $20.02 M(+1.8%) | $76.48 M(+6.3%) |
June 2024 | - | $19.66 M(-4.4%) | $71.96 M(+4.4%) |
Mar 2024 | - | $20.56 M(+26.5%) | $68.95 M(+2.3%) |
Dec 2023 | $67.39 M(+9.6%) | $16.25 M(+4.9%) | $67.39 M(-0.6%) |
Sept 2023 | - | $15.50 M(-6.9%) | $67.76 M(+0.6%) |
June 2023 | - | $16.65 M(-12.3%) | $67.38 M(+2.1%) |
Mar 2023 | - | $18.99 M(+14.2%) | $65.96 M(+7.3%) |
Dec 2022 | $61.46 M(+21.7%) | $16.63 M(+10.0%) | $61.46 M(+5.3%) |
Sept 2022 | - | $15.11 M(-0.8%) | $58.39 M(+2.6%) |
June 2022 | - | $15.23 M(+5.2%) | $56.89 M(+7.2%) |
Mar 2022 | - | $14.49 M(+6.9%) | $53.08 M(+5.1%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2021 | $50.52 M(+44.9%) | $13.56 M(-0.4%) | $50.52 M(+3.0%) |
Sept 2021 | - | $13.61 M(+19.1%) | $49.02 M(+13.2%) |
June 2021 | - | $11.43 M(-4.2%) | $43.30 M(+11.9%) |
Mar 2021 | - | $11.93 M(-1.1%) | $38.70 M(+11.0%) |
Dec 2020 | $34.86 M(+13.8%) | $12.06 M(+53.1%) | $34.86 M(+18.8%) |
Sept 2020 | - | $7.88 M(+15.3%) | $29.35 M(-1.1%) |
June 2020 | - | $6.83 M(-15.4%) | $29.68 M(+29.9%) |
Mar 2020 | - | $8.08 M(+23.2%) | $22.85 M(+54.7%) |
Dec 2019 | $30.64 M(+18.3%) | $6.56 M(-20.2%) | $14.77 M(+79.8%) |
Sept 2019 | - | $8.21 M | $8.21 M |
Dec 2018 | $25.90 M | - | - |
FAQ
- What is Biodesix annual selling, general & administrative expenses?
- What is the all time high annual SG&A for Biodesix?
- What is Biodesix annual SG&A year-on-year change?
- What is Biodesix quarterly selling, general & administrative expenses?
- What is the all time high quarterly SG&A for Biodesix?
- What is Biodesix quarterly SG&A year-on-year change?
- What is Biodesix TTM selling, general & administrative expenses?
- What is the all time high TTM SG&A for Biodesix?
- What is Biodesix TTM SG&A year-on-year change?
What is Biodesix annual selling, general & administrative expenses?
The current annual SG&A of BDSX is $67.39 M
What is the all time high annual SG&A for Biodesix?
Biodesix all-time high annual selling, general & administrative expenses is $67.39 M
What is Biodesix annual SG&A year-on-year change?
Over the past year, BDSX annual selling, general & administrative expenses has changed by +$5.92 M (+9.64%)
What is Biodesix quarterly selling, general & administrative expenses?
The current quarterly SG&A of BDSX is $20.02 M
What is the all time high quarterly SG&A for Biodesix?
Biodesix all-time high quarterly selling, general & administrative expenses is $20.56 M
What is Biodesix quarterly SG&A year-on-year change?
Over the past year, BDSX quarterly selling, general & administrative expenses has changed by +$4.52 M (+29.17%)
What is Biodesix TTM selling, general & administrative expenses?
The current TTM SG&A of BDSX is -$1.75 B
What is the all time high TTM SG&A for Biodesix?
Biodesix all-time high TTM selling, general & administrative expenses is $76.48 M
What is Biodesix TTM SG&A year-on-year change?
Over the past year, BDSX TTM selling, general & administrative expenses has changed by -$1.82 B (-2684.01%)